CVS replaces CEO Karen Lynch with exec David Joyner

Longtime CVS Health executive David Joyner has succeeded Karen Lynch as CEO, as the company struggles to drive higher profits and stock performance, CVS announced Friday. The move, effective Thursday, the day before the announcement, comes as CVS shares have fallen nearly 20% this year. The stock closed around 5% lower on Friday. CVS has faced challenges as higher…

Read more

Novavax shares plunge as company says FDA put hold on two shots

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Wednesday said the Food and Drug Administration has put a hold on its application for a combination shot targeting Covid and…

Read more